Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial

BACKGROUND AND PURPOSE: Moderate-intensity statin plus ezetimibe versus high-intensity statin alone may provide a greater low-density lipoprotein cholesterol (LDL-C) reduction in patients with recent ischemic stroke. METHODS: This randomized, open-label, controlled trial assigned patients with recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Keun-Sik, Bang, Oh Young, Park, Jong-Ho, Jung, Jin-Man, Lee, Sang-Hun, Song, Tae-Jin, Nam, Hyo Suk, Park, Hee-Kwon, Jung, Keun-Hwa, Heo, Sung Hyuk, Koo, Jaseong, Yu, Kyung-Ho, Park, Kwang-Yeol, Kim, Chi Kyung, Park, Hong-Kyun, Lee, Jiyoon, Lee, Juneyoung, Seo, Woo-Keun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Stroke Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250871/
https://www.ncbi.nlm.nih.gov/pubmed/37032475
http://dx.doi.org/10.5853/jos.2022.02957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250871/
https://www.ncbi.nlm.nih.gov/pubmed/37032475
http://dx.doi.org/10.5853/jos.2022.02957

Ejemplares similares